Apogee Enterprises Inc APOG

$42.58 +0.02% at last close

Analyst Consensus

Consensus Rating
Buy (1 Buy · 0 Hold · 0 Sell)
Average Price Target
$47.00
Implied Upside
+10.4%
Price Target Range
$47.00 – $47.00
Analysts (12 mo)
1

Recent Analyst Actions

DateFirmActionRatingPrice Target
2025-11-17
DA DavidsonBrent Thielman
Upgrades Neutral → Buy $47
2025-07-01
DA DavidsonBrent Thielman
Maintains Neutral $47 → $45
2025-01-08
DA DavidsonBrent Thielman
Maintains Neutral $75 → $62
2024-10-08
DA DavidsonBrent Thielman
Maintains Neutral $65 → $75
2024-06-28
DA DavidsonBrent Thielman
Maintains Neutral $60 → $65
2023-04-13
Craig-HallumEric Stine
Maintains Hold $45 → $46
2022-06-24
Craig-HallumEric Stine
Maintains Hold $47 → $43
2022-04-08
Craig-HallumEric Stine
Downgrades Buy → Hold
2020-05-13
Sidoti & Co.
Maintains Neutral $21 → $19
2019-12-20
DA DavidsonBrent Thielman
Maintains Neutral $35 → $40
2018-06-29
DA DavidsonBrent Thielman
Downgrades Buy → Neutral $47 → $52
2018-04-04
Goldman SachsSamuel Eisner
Downgrades Neutral → Sell
2017-01-19
Craig-HallumEric Stine
Initiates coverage on Buy $68
2016-07-12
Goldman SachsSamuel Eisner
Downgrades Buy → Neutral $53 → $50
2015-06-26
Northland Capital Markets
Downgrades Outperform → Market perform
2015-06-15
DA DavidsonBrent Thielman
Maintains Buy $58 → $64
2014-11-17
DA DavidsonBrent Thielman
Maintains Buy $46 → $52
2014-09-23
Northland Capital Markets
Upgrades Market perform → Outperform $33 → $47
2014-05-19
DA DavidsonBrent Thielman
Upgrades Neutral → Buy $36
2013-12-20
Northland Capital Markets
Downgrades Outperform → Market perform $33
2013-10-01
Goldman SachsSamuel Eisner
Initiates coverage on Buy $38

Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.

Key Stats

Last Close
$42.58
Market Cap
$888.57 million
52-Week Range
$30.75 $50.88
Average Volume
191K shs

Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.